NM
Newtyn Management Portfolio holdings
AUM
$660M
This Quarter Return
+16.98%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$485M
AUM Growth
+$29.1M
(+6.4%)
Cap. Flow
-$19M
Cap. Flow
% of AUM
-3.92%
Top 10 Holdings %
Top 10 Hldgs %
51.57%
Holding
81
New
1
Increased
35
Reduced
19
Closed
10
Top Buys
| 1 |
IAC Inc
IAC
|
$19.1M |
| 2 |
Ardagh Metal Packaging
AMBP
|
$4.77M |
| 3 |
1-800-Flowers.com
FLWS
|
$4.36M |
| 4 |
SAFE
Safehold
SAFE
|
$4.04M |
| 5 |
Destination XL Group
DXLG
|
$3.58M |
Top Sells
| 1 |
Sylvamo
SLVM
|
$14.9M |
| 2 |
Theravance Biopharma
TBPH
|
$11.7M |
| 3 |
AVTA
Avantax, Inc. Common Stock
AVTA
|
$7.05M |
| 4 |
Virtus Investment Partners
VRTS
|
$5.09M |
| 5 |
PG&E
PCG
|
$4.57M |
Sector Composition
| 1 | Consumer Discretionary | 22.15% |
| 2 | Healthcare | 21.39% |
| 3 | Financials | 12.53% |
| 4 | Real Estate | 9.47% |
| 5 | Communication Services | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Phathom Pharmaceuticals
PHAT
$843M
| $5.43M | 1.12% |
484,074
+168,099
| +53% | +$1.89M |
|
27
Tilly's
TLYS
$61.2M
| $4.95M | 1.02% |
547,463
-23,687
| -4% | -$214K |
|
|
28
PG&E
PCG
$33.7B
| $4.37M | 0.9% |
268,921
-281,079
| -51% | -$4.57M |
|
29
Customers Bancorp
CUBI
$2.29B
| $4.25M | 0.88% |
150,000
| – | – |
|
30
Wave Life Sciences
WVE
$1.27B
| $4.2M | 0.87% |
600,000
| – | – |
|
31
Stitch Fix
SFIX
$692M
| $4.03M | 0.83% |
1,295,000
+365,800
| +39% | +$1.14M |
|
32
89bio
ETNB
$1.37B
| $3.95M | 0.81% |
310,000
| – | – |
|
33
Algoma Steel
ASTL
$507M
| $3.75M | 0.77% |
590,899
| – | – |
|
|
IVAC
34
DELISTED
Intevac Inc
IVAC
| $3.36M | 0.69% |
520,000
| – | – |
|
|
NXDT
35
NexPoint Diversified Real Estate Trust
NXDT
$177M
| $2.8M | 0.58% |
250,000
| – | – |
|
36
Collegium Pharmaceutical
COLL
$1.25B
| $2.44M | 0.5% |
105,000
| – | – |
|
37
Pyxis Oncology
PYXS
$91.2M
| $2.01M | 0.41% |
1,500,000
+700,000
| +88% | +$938K |
|
38
Sensei Biotherapeutics
SNSE
$10.9M
| $1.72M | 0.36% |
57,778
+37,028
| +178% | +$1.1M |
|
|
CYT
39
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $1.68M | 0.35% |
1,020,000
+365,888
| +56% | +$604K |
|
40
ATAI Life Sciences
ATAI
$969M
| $1.6M | 0.33% |
600,000
+130,000
| +28% | +$346K |
|
41
Bolt Biotherapeutics
BOLT
$9.29M
| $1.5M | 0.31% |
57,500
+27,500
| +92% | +$715K |
|
|
DNMR
42
DELISTED
Danimer Scientific, Inc.
DNMR
| $1.43M | 0.3% |
20,000
+4,375
| +28% | +$313K |
|
43
Aligos Therapeutics
ALGS
$75.1M
| $1.43M | 0.3% |
60,000
+20,000
| +50% | +$476K |
|
44
Invivyd
IVVD
$218M
| $1.35M | 0.28% |
900,000
+550,000
| +157% | +$825K |
|
45
Alector
ALEC
$282M
| $1.34M | 0.28% |
145,000
+40,000
| +38% | +$369K |
|
|
SIOX
46
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.31M | 0.27% |
3,000,000
+1,500,000
| +100% | +$653K |
|
|
ORKA
47
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
| $1.27M | 0.26% |
44,857
+3,190
| +8% | +$90.3K |
|
48
Passage Bio
PASG
$22.6M
| $1.09M | 0.23% |
39,500
+24,500
| +163% | +$676K |
|
|
TCRR
49
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.07M | 0.22% |
1,075,000
+475,000
| +79% | +$474K |
|
|
LTCH
50
DELISTED
Latch, Inc. Common Stock
LTCH
| $1.06M | 0.22% |
1,490,000
+490,000
| +49% | +$348K |
|